Literature DB >> 18176033

A canine case of skull base meningioma treated with hydroxyurea.

Shinji Tamura1, Yumiko Tamura, Aya Ohoka, Takahisa Hasegawa, Kazuyuki Uchida.   

Abstract

An 11-year-old female miniature schnauzer was tentatively diagnosed with the skull base meningioma, based on several examinations. Because surgical treatment was difficult, and outpatient radiation therapy was not available in the local area, chemotherapy with hydroxyurea combined with dexamethasone was selected. The patient's clinical symptoms improved after one week of treatment, and the tumor size was obviously reduced on MRI performed 37 days after treatment began. The patient received hydroxyurea for 7 months, with symptoms remaining stable, and the tumor re-increased to almost the same size at 7 months as that at the initial examination. At that time, hydroxyurea was discontinued. The patient died from pulmonary edema 14 months after treatment began. Pathologically, the tumor was diagnosed as a meningioma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18176033     DOI: 10.1292/jvms.69.1313

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  7 in total

1.  Characteristics of 18F-FDG and 18F-FDOPA PET in an 8-year-old neutered male Yorkshire Terrier dog with glioma: long-term chemotherapy using hydroxyurea plus imatinib with prednisolone and immunoreactivity for PDGFR-β and LAT1.

Authors:  Taesik Yun; Yoonhoi Koo; Sanggu Kim; Wonguk Lee; Hakhyun Kim; Dongwoo Chang; Soochong Kim; Mhan-Pyo Yang; Byeong-Teck Kang
Journal:  Vet Q       Date:  2021-12       Impact factor: 3.320

2.  Imatinib mesylate plus hydroxyurea chemotherapy for cerebellar meningioma in a Belgian Malinois dog.

Authors:  Hae-Won Jung; Hee-Chun Lee; Ji-Hyun Kim; Hyo-Mi Jang; Jong-Hyun Moon; Jung-Hyang Sur; Jeongim Ha; Dong-In Jung
Journal:  J Vet Med Sci       Date:  2014-08-13       Impact factor: 1.267

3.  Clinical presentation, diagnostic findings and outcome of dogs undergoing surgical resection for intracranial meningioma: 101 dogs.

Authors:  Alexander K Forward; Holger Andreas Volk; Giunio Bruto Cherubini; Tom Harcourt-Brown; Ioannis N Plessas; Laurent Garosi; Steven De Decker
Journal:  BMC Vet Res       Date:  2022-03-07       Impact factor: 2.741

4.  Case Report: 18F-Fluoro-L-Phenylalanine Positron Emission Tomography Findings and Immunoreactivity for L-Type Amino Acid Transporter 1 in a Dog With Meningioma.

Authors:  Dohee Lee; Taesik Yun; Sanggu Kim; Yoonhoi Koo; Yeon Chae; Soochong Kim; Dongwoo Chang; Mhan-Pyo Yang; Hakhyun Kim; Byeong-Teck Kang
Journal:  Front Vet Sci       Date:  2022-07-15

Review 5.  Advances in diagnostic and treatment modalities for intracranial tumors.

Authors:  P J Dickinson
Journal:  J Vet Intern Med       Date:  2014-05-09       Impact factor: 3.333

6.  Choroid plexus papilloma in a dog surviving for 15 months after diagnosis with symptomatic therapy.

Authors:  Teruo Itoh; Kazuyuki Uchida; Atsuko Nishi; Hiroki Shii; Takako Nagayoshi; Hiroshi Sakamoto
Journal:  J Vet Med Sci       Date:  2015-08-28       Impact factor: 1.267

7.  Long-term follow-up of surgical resection alone for primary intracranial rostrotentorial tumors in dogs: 29 cases (2002-2013).

Authors:  Anna Suñol; Joan Mascort; Cristina Font; Alicia Rami Bastante; Martí Pumarola; Alejandro Lujan Feliu-Pascual
Journal:  Open Vet J       Date:  2017-12-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.